INSPIRE THERAPY FOR CANINE MAMMARY CARCINOMA
Principal Investigator
Description
This study is looking for dogs with 1-2 discrete mammary tumors measuring between 1-3cm to participate in a clinical trial that is investigating a new therapy called INSPIRE, which uses electrical pulses to safely destroy the membranes of cells within a tumor.
Owners would need to bring their dog to the NC State Veterinary Hospital for a screening appointment. to see if the patient is eligible to participate in the clinical trail. The screening includes a cardiology and oncology consult, thoracic radiographs, abdominal ultrasound, bloodwork, and initial CT scan
If patients are eligible for enrollment after the screening appointment, they will return a week later for a single INSPIRE treatment. Followed by four recheck appointments over 9 months that include bloodwork and a CT scan.
Testing Requirements
Patients who are suspected of having mammary carcinoma.
Enrollment Start
7/01/2023
Enrollment Finish
7/01/2024
Eligibility
• Patients that have 1-2 discrete tumors measuring between 1-3cm
• Patients must weigh at least 30lbs
• Patients that have been previously spayed
Exclusions
• Patients that have tumors greater than 4cm
• Patients that are in poor health
• Patients that are not eligible for general anesthesia
• Tumors that have metastasized
Flyer
Contact
Jewels Darrow: 919 515 9130 OR CVMclinicalstudies@ncsu.edu
- Categories: